RecruitingNot ApplicableNCT05491005

The eHealth Diabetes Remission Trial

eHealth Diabetes Remission Trial (Swedish: Remission av Typ 2 Diabetes Med hjälp av eHälsa

Sponsor

Umeå University

Enrollment

106 participants

Start Date

Aug 31, 2022

Study Type

INTERVENTIONAL

Conditions

Diabetes Mellitus, Type 2

Summary

Overweight patients with type 2 diabetes are offered a total diet replacement with the goal of weight loss and diabetes remission. Study participants are randomised to eHealth follow-up or face-to-face follow-up, but the dietary advice is the same in both groups. A healthy control group with normal glucose tolerance is examined once but is not randomised and does not receive any intervention.

Eligibility

Min Age: 20 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether an eHealth (online) program can help put Type 2 diabetes into remission — meaning blood sugar levels return to normal without medication. The program focuses on intensive lifestyle changes, including a very low-calorie diet, delivered through a digital platform. **You may be eligible if...** - You have Type 2 diabetes diagnosed within the last 6 years - Your BMI is 27 or higher - Your HbA1c (a 3-month blood sugar measure) meets the required threshold **You may NOT be eligible if...** - You use insulin - You have lost more than 5 kg in the past 6 months - You have a diagnosed eating disorder - Your kidney function is significantly reduced (eGFR below 30) - You had a heart attack in the last 6 months - You have severe heart failure - You have ongoing cancer - You are pregnant - You take antipsychotic medications Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALTotal diet replacement

Total diet replacement (850 kcal/day) for 3 months followed by weight maintenance for 21 months.

BEHAVIORALeHealth

All follow-up through an eHealth application and video meetings.

BEHAVIORALFace-to-face

All follow-up through face-to-face meetings.

Locations(3)

Bra Liv Råslätt vårdcentral

Jönköping, Sweden

Örnsköldsvik hospital

Örnsköldsvik, Sweden

Department of Public Health and Clinical Medicine, Medicine

Umeå, Sweden

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05491005

Related Trials

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

NCT070644731152 locations

Mixed Methods Study of Health-Related Social Needs in African American Adults With Chronic Kidney Disease and Type 2 Diabetes Mellitus

NCT056923881 location

Implementing Scalable, PAtient-centered, Team-based, Technology-enabled Care for Adults With Type 2 Diabetes (iPATH)

NCT062513234 locations

A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal Insulin

NCT0721531226 locations

Gemini Study: A Prospective, Multicenter Evaluation of Performance and Safety of the Eversense Gemini System With Flash Glucose Measurement Feature

NCT073863401 location